Key result
Sivelestat boosts survival to ~81% versus controls in mice with endotoxemia-induced myocardial injury.
Why the study?
The contribution of neutrophil elastase to myocardial injury in sepsis was unknown.
Does neutrophil elastase inhibition with sivelestat improve survival and reduce myocardial injury in a mouse model of endotoxemia?
Does neutrophil elastase inhibition with sivelestat improve survival and reduce myocardial injury in a mouse model of endotoxemia?
Absolute Event Rate: 81% vs 22%
p-value: p=<0.05
Neutrophil elastase inhibition with sivelestat ameliorates endotoxin-induced myocardial injury and improves survival in a mouse model of sepsis.
Myocardial injury in sepsis may be caused by a burst of several inflammatory mediators, leading to vascular endothelial injuries. However, the contribution of neutrophil elastase (NE) to myocardial injury in sepsis is still unknown. We aimed to evaluate whether endotoxemia-induced myocardial injury is associated with NE. Lipopolysaccharide (LPS) was injected intraperitoneally at a dose of 20 mg/kg into granulocyte-colony-stimulating-factor knockout mice (G-CSF-KO), which have few neutrophils, and littermate control mice. The survival rate of G-CSF-KO mice 48 hours after LPS injection was significantly greater than that of control mice. The serum level of troponin I in G-CSF-KO mice was significantly lower than that in control mice. In addition, the concentration of inflammatory cytokine interleukin-6 (IL-6) was significantly decreased 6 and 12 hours after LPS administration compared with that in control mice. Ultrastructural analysis revealed that vascular endothelial structures and the endothelial glycocalyx in G-CSF-KO mice were clearly preserved. Next, mice were injected with 0.2 mg/kg sivelestat (an NE inhibitor) after LPS administration. The survival rate was significantly higher and the serum level of troponin I was lower in sivelestat-injected mice than in control mice, respectively. Furthermore, IL-6 levels were significantly decreased 6 and 12 hours after LPS administration compared with those in control mice. Vascular endothelial structures and the endothelial glycocalyx in sivelestat-treated mice were clearly preserved at the ultrastructural level. In conclusion, NE is significantly associated with myocardial injury in endotoxemia. Inhibition of NE may be a useful tool for the management of endotoxemia.
No takes yet. Share an insight, caveat, or question.
Fukuta et al. (2019) studied Endotoxemia-induced myocardial injury. Sivelestat vs. Isotonic saline was evaluated on Survival rate at 48 hours (p=<0.05). Sivelestat, a neutrophil elastase inhibitor, significantly increased the 48-hour survival rate to 81% compared to 22% in control mice with endotoxemia-induced myocardial injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: